Literature DB >> 24251027

Minimally invasive mitral surgery through right mini-thoracotomy under direct vision.

Alison F Ward1, Eugene A Grossi, Aubrey C Galloway.   

Abstract

In the 1990s, the success of 'minimally invasive' laparoscopic operations in other surgical subspecialties sparked an interest in minimally-invasive approaches for cardiac surgery, specifically for mitral valve repair. In 1996 at New York University (NYU) we began our experience with minimally invasive mitral valve repair performed through a small right anterior mini-thoracotomy incision using the Port-Access system in a phase I clinical trial. This was the beginning of our extensive right mini-thoracotomy experience for mitral valve repair at NYU. Currently at our institution the preferred approach for the right mini-thoracotomy mitral valve surgery is through the 3rd or 4th interspace mini-thoracotomy incision. Perfusion is accomplished with direct aortic or femoral cannulation, long femoral venous cannula drainage, and a retrograde cardioplegia catheter placed trans-atrialy in the coronary sinus under TEE guidance. An antegrade cardioplegia and venting needle is placed in the ascending aorta and direct external aortic clamping is achieved with one of several specialized crossclamps. With over four decades of experience, more than 4,000 patients have undergone mitral valve repair at NYU including 1,922 performed through a right mini-thoracotomy. We have reported an overall operative mortality of 1.3%, 8-year freedom from reoperation of 95%, freedom from reoperation or severe recurrent mitral regurgitation of 93%, and freedom from all valve-related complications of 90% for our initial series of 1,071 right mini-thoracotomy mitral valve repair. Based on our extensive experience we believe that mitral valve repair through a right mini-thoracotomy provides a durable and safe alternative to a traditional sternotomy with the benefits of improved cosmesis, reduced post-operative pain, less blood loss with fewer blood transfusions, fewer infections, shorter length of stay, and faster return to activity. It is our standard of care approach for mitral valve surgery.

Entities:  

Keywords:  Mitral valve (MV); minimally invasive surgical procedures; mitral valve insufficiency; mitral valve repair (MVr)

Year:  2013        PMID: 24251027      PMCID: PMC3831832          DOI: 10.3978/j.issn.2072-1439.2013.10.09

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  33 in total

1.  Minimally invasive versus sternotomy approaches for mitral reconstruction: comparison of intermediate-term results.

Authors:  E A Grossi; A LaPietra; G H Ribakove; J Delianides; R Esposito; A T Culliford; C C Derivaux; R M Applebaum; I Kronzon; B M Steinberg; F G Baumann; A C Galloway; S B Colvin
Journal:  J Thorac Cardiovasc Surg       Date:  2001-04       Impact factor: 5.209

2.  Minimally invasive mitral valve surgery: a 6-year experience with 714 patients.

Authors:  Eugene A Grossi; Aubrey C Galloway; Angelo LaPietra; Greg H Ribakove; Patricia Ursomanno; Julie Delianides; Alfred T Culliford; Costas Bizekis; Rick A Esposito; F Gregory Baumann; Marc S Kanchuger; Stephen B Colvin
Journal:  Ann Thorac Surg       Date:  2002-09       Impact factor: 4.330

3.  Port-access cardiac operations with cardioplegic arrest.

Authors:  J I Fann; M F Pompili; J H Stevens; L C Siegel; F G St Goar; T A Burdon; B A Reitz
Journal:  Ann Thorac Surg       Date:  1997-06       Impact factor: 4.330

4.  Minimal invasive mitral valve repair for mitral regurgitation: results of 1339 consecutive patients.

Authors:  Joerg Seeburger; Michael Andrew Borger; Volkmar Falk; Thomas Kuntze; Markus Czesla; Thomas Walther; Nicolas Doll; Friedrich Wilhelm Mohr
Journal:  Eur J Cardiothorac Surg       Date:  2008-06-30       Impact factor: 4.191

5.  Minimally invasive versus conventional open mitral valve surgery: a meta-analysis and systematic review.

Authors:  Davy C H Cheng; Janet Martin; Avtar Lal; Anno Diegeler; Thierry A Folliguet; L Wiley Nifong; Patrick Perier; Ehud Raanani; J Michael Smith; Joerg Seeburger; Volkmar Falk
Journal:  Innovations (Phila)       Date:  2011-03

6.  Minimally invasive mitral valve operations.

Authors:  J L Navia; D M Cosgrove
Journal:  Ann Thorac Surg       Date:  1996-11       Impact factor: 4.330

7.  Cardiac valve surgery--the "French correction".

Authors:  A Carpentier
Journal:  J Thorac Cardiovasc Surg       Date:  1983-09       Impact factor: 5.209

8.  Impact of minimally invasive valvular heart surgery: a case-control study.

Authors:  E A Grossi; A C Galloway; G H Ribakove; P K Zakow; C C Derivaux; F G Baumann; D Schwesinger; S B Colvin
Journal:  Ann Thorac Surg       Date:  2001-03       Impact factor: 4.330

9.  Minimally invasive versus sternotomy approach for mitral valve surgery in patients greater than 70 years old: a propensity-matched comparison.

Authors:  David M Holzhey; William Shi; Michael A Borger; Joerg Seeburger; Jens Garbade; Bettina Pfannmüller; Friedrich W Mohr
Journal:  Ann Thorac Surg       Date:  2011-02       Impact factor: 4.330

10.  Small-incision mitral valve repair: safe, durable, and approaching perfection.

Authors:  James S Gammie; Stephen T Bartlett; Bartley P Griffith
Journal:  Ann Surg       Date:  2009-09       Impact factor: 12.969

View more
  9 in total

Review 1.  Minimally invasive mitral valve surgery through right mini-thoracotomy: recommendations for good exposure, stable cardiopulmonary bypass, and secure myocardial protection.

Authors:  Toshiaki Ito
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-04-04

Review 2.  Videoscope-assisted cardiac surgery.

Authors:  Kuan-Ming Chiu; Robert Jeen-Chen Chen
Journal:  J Thorac Dis       Date:  2014-01       Impact factor: 2.895

3.  Right minithoracotomy versus conventional median sternotomy for patients undergoing mitral valve surgery and Cox-maze IV ablation with entirely bipolar radiofrequency clamp.

Authors:  Zhaolei Jiang; Min Tang; Nan Ma; Hao Liu; Fangbao Ding; Chunrong Bao; Ju Mei
Journal:  Heart Vessels       Date:  2018-02-02       Impact factor: 2.037

4.  Perioperative management of patient with Bombay blood group undergoing mitral valve replacement.

Authors:  Shio Priye; J Sathyanarayan; S Shivaprakash; Durgaprasad Reddy
Journal:  Indian J Anaesth       Date:  2015-12

5.  Peripheral vascular complications following totally endoscopic cardiac surgery.

Authors:  Ling-Chen Huang; Qi-Chen Xu; Dao-Zhong Chen; Xiao-Fu Dai; Liang-Wan Chen
Journal:  J Cardiothorac Surg       Date:  2021-03-20       Impact factor: 1.637

6.  Totally endoscopic mitral valve surgery: early experience in 188 patients.

Authors:  Yi Chen; Ling-Chen Huang; Dao-Zhong Chen; Liang-Wan Chen; Zi-He Zheng; Xiao-Fu Dai
Journal:  J Cardiothorac Surg       Date:  2021-04-17       Impact factor: 1.637

7.  Upper Hemi-Sternotomy Provides Benefit for Patients with Isolated or Combined Mitral Valve Surgery.

Authors:  Cenk Ulvi Oezpeker; Fabian Barbieri; Daniel Hoefer; Nikolaos Bonaros; Michael Grimm; Ludwig Mueller
Journal:  Medicina (Kaunas)       Date:  2022-01-18       Impact factor: 2.430

8.  Minimally Invasive Mitral Valve Surgery II: Surgical Technique and Postoperative Management.

Authors:  J Alan Wolfe; S Chris Malaisrie; R Saeid Farivar; Junaid H Khan; W Clark Hargrove; Michael G Moront; William H Ryan; Gorav Ailawadi; Arvind K Agnihotri; Brian W Hummel; Trevor M Fayers; Eugene A Grossi; T Sloane Guy; Eric J Lehr; John R Mehall; Douglas A Murphy; Evelio Rodriguez; Arash Salemi; Romualdo J Segurola; Richard J Shemin; J Michael Smith; Robert L Smith; Paul W Weldner; Clifton T P Lewis; Glenn R Barnhart; Scott M Goldman
Journal:  Innovations (Phila)       Date:  2016 Jul-Aug

9.  Early and long-term results of minimally invasive mitral valve surgery through a right mini-thoracotomy approach: a retrospective propensity-score matched analysis.

Authors:  Sabreen Mkalaluh; Marcin Szczechowicz; Bashar Dib; Anton Sabashnikov; Gabor Szabo; Matthias Karck; Alexander Weymann
Journal:  PeerJ       Date:  2018-05-28       Impact factor: 2.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.